DEF 14AThe Ballot
Niagen Bioscience, Inc. files DEF 14A
Filed Apr 27, 2022 · 4y ago · Accession 0001628280-22-010816
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- Niagen Bioscience, Inc.
- Ticker
- NAGE
- CIK
- 1386570
- Form type
- DEF 14A
- Filing date
- Apr 27, 2022
- Report date
- Jun 16, 2022
- Document
- cdxcproxystatement2022def1.htm
- Size
- 1.0 MB